Dr. Andrew Blight Acorda Therapeutics, USA

Andrew Blight is responsible for R&D activities at Acorda Therapeutics. He received his undergraduate and graduate training at the University of Bristol (UK) and spent 20 years as an academic neuroscience and neurotrauma researcher before joining Acorda full time in 1998. He has broad interests in the pathology and treatment... read moreof neural trauma.